257 related articles for article (PubMed ID: 32881209)
1. Approach to the Patient with COVID-19-Associated Thrombosis: A Case-Based Review.
Chen EC; Zon RL; Battinelli EM; Connors JM
Oncologist; 2020 Oct; 25(10):e1500-e1508. PubMed ID: 32881209
[TBL] [Abstract][Full Text] [Related]
2. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.
Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P
Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 and its implications for thrombosis and anticoagulation.
Connors JM; Levy JH
Blood; 2020 Jun; 135(23):2033-2040. PubMed ID: 32339221
[TBL] [Abstract][Full Text] [Related]
4. Complement activation and coagulopathy - an ominous duo in COVID19.
Tomo S; Kumar KP; Roy D; Sankanagoudar S; Purohit P; Yadav D; Banerjee M; Sharma P; Misra S
Expert Rev Hematol; 2021 Feb; 14(2):155-173. PubMed ID: 33480807
[TBL] [Abstract][Full Text] [Related]
5. How to recognize and manage COVID-19-associated coagulopathy.
Gerber GF; Chaturvedi S
Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):614-620. PubMed ID: 34889412
[TBL] [Abstract][Full Text] [Related]
6. Nuts and bolts of COVID-19 associated coagulopathy: the essentials for management and treatment.
Lindsay PJ; Rosovsky R; Bittner EA; Chang MG
Postgrad Med; 2021 Nov; 133(8):899-911. PubMed ID: 34470540
[TBL] [Abstract][Full Text] [Related]
7. [Title: Covid-19-associated coagulopathy].
Nopp S; Ay C
Dtsch Med Wochenschr; 2021 Aug; 146(15):944-949. PubMed ID: 34344026
[TBL] [Abstract][Full Text] [Related]
8. Venous thrombosis epidemiology, pathophysiology, and anticoagulant therapies and trials in severe acute respiratory syndrome coronavirus 2 infection.
Obi AT; Barnes GD; Napolitano LM; Henke PK; Wakefield TW
J Vasc Surg Venous Lymphat Disord; 2021 Jan; 9(1):23-35. PubMed ID: 32916371
[TBL] [Abstract][Full Text] [Related]
9. Haematological manifestations of COVID-19: From cytopenia to coagulopathy.
Agbuduwe C; Basu S
Eur J Haematol; 2020 Nov; 105(5):540-546. PubMed ID: 32663356
[TBL] [Abstract][Full Text] [Related]
10. Coagulopathy in COVID-19: Manifestations and management.
Mucha SR; Dugar S; McCrae K; Joseph D; Bartholomew J; Sacha GL; Militello M
Cleve Clin J Med; 2020 Jul; 87(8):461-468. PubMed ID: 32409435
[TBL] [Abstract][Full Text] [Related]
11. D-Dimer, Fibrinogen, and IL-6 in COVID-19 Patients with Suspected Venous Thromboembolism: A Narrative Review.
Eljilany I; Elzouki AN
Vasc Health Risk Manag; 2020; 16():455-462. PubMed ID: 33223833
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 Coagulopathy: Current knowledge and guidelines on anticoagulation.
Salabei JK; Fishman TJ; Asnake ZT; Ali A; Iyer UG
Heart Lung; 2021; 50(2):357-360. PubMed ID: 33524866
[TBL] [Abstract][Full Text] [Related]
13. COVID-19-Associated Systemic Thromboembolism: A Case Report and Review of the Literature.
Mahajan P; Dass B; Radhakrishnan N; McCullough PA
Cardiorenal Med; 2020; 10(6):462-469. PubMed ID: 33091905
[TBL] [Abstract][Full Text] [Related]
14. Coagulation and anticoagulation in COVID-19.
Hadid T; Kafri Z; Al-Katib A
Blood Rev; 2021 May; 47():100761. PubMed ID: 33067035
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 Infection: Viral Macro- and Micro-Vascular Coagulopathy and Thromboembolism/Prophylactic and Therapeutic Management.
Manolis AS; Manolis TA; Manolis AA; Papatheou D; Melita H
J Cardiovasc Pharmacol Ther; 2021 Jan; 26(1):12-24. PubMed ID: 32924567
[TBL] [Abstract][Full Text] [Related]
16. Coagulopathy in COVID-19.
Iba T; Levy JH; Levi M; Thachil J
J Thromb Haemost; 2020 Sep; 18(9):2103-2109. PubMed ID: 32558075
[TBL] [Abstract][Full Text] [Related]
17. SARS-COV-2-associated coagulopathy and thromboembolism prophylaxis in children: A single-center observational study.
Del Borrello G; Giraudo I; Bondone C; Denina M; Garazzino S; Linari C; Mignone F; Pruccoli G; Scolfaro C; Spadea M; Pollio B; Saracco P
J Thromb Haemost; 2021 Feb; 19(2):522-530. PubMed ID: 33305475
[TBL] [Abstract][Full Text] [Related]
18. COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation.
Miesbach W; Makris M
Clin Appl Thromb Hemost; 2020; 26():1076029620938149. PubMed ID: 32677459
[TBL] [Abstract][Full Text] [Related]
19. Impaired coagulation, liver dysfunction and COVID-19: Discovering an intriguing relationship.
D'Ardes D; Boccatonda A; Cocco G; Fabiani S; Rossi I; Bucci M; Guagnano MT; Schiavone C; Cipollone F
World J Gastroenterol; 2022 Mar; 28(11):1102-1112. PubMed ID: 35431501
[TBL] [Abstract][Full Text] [Related]
20. Incidence of Venous Thromboembolism in Critically Ill Coronavirus Disease 2019 Patients Receiving Prophylactic Anticoagulation.
Trigonis RA; Holt DB; Yuan R; Siddiqui AA; Craft MK; Khan BA; Kapoor R; Rahman O
Crit Care Med; 2020 Sep; 48(9):e805-e808. PubMed ID: 32618699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
